EUR 9.72
(-0.41%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 115.93 Million EUR | -22.39% |
2022 | -1.01 Million EUR | 20.97% |
2021 | -1.28 Million EUR | -42.4% |
2020 | -901 Thousand EUR | -101.58% |
2019 | 57.09 Million EUR | 14.19% |
2018 | 49.99 Million EUR | 178.36% |
2017 | 17.96 Million EUR | -48.61% |
2016 | 34.95 Million EUR | 5.32% |
2015 | 33.18 Million EUR | 0.6% |
2014 | 32.98 Million EUR | 2.94% |
2013 | 32.04 Million EUR | 22.32% |
2012 | 26.19 Million EUR | -25.03% |
2011 | 34.94 Million EUR | 4.45% |
2010 | 33.45 Million EUR | 3.01% |
2009 | 32.47 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | -608 Thousand EUR | 3412.74% |
2023 FY | -1.24 Million EUR | -22.39% |
2023 Q2 | 525 Thousand EUR | 278.57% |
2023 Q4 | -1.76 Million EUR | -436.38% |
2022 Q4 | -294 Thousand EUR | 59.17% |
2022 FY | -1.01 Million EUR | 20.97% |
2022 Q2 | -720 Thousand EUR | -267.05% |
2021 Q2 | -1.71 Million EUR | -33.91% |
2021 FY | -1.28 Million EUR | -42.4% |
2021 Q4 | 431 Thousand EUR | 125.15% |
2020 Q4 | -1.28 Million EUR | -437.73% |
2020 Q2 | 379 Thousand EUR | 230.24% |
2020 FY | -901 Thousand EUR | -101.58% |
2019 Q4 | -291 Thousand EUR | -101.02% |
2019 FY | 57.09 Million EUR | 14.19% |
2019 Q2 | 28.55 Million EUR | 11.11% |
2018 Q4 | 25.7 Million EUR | 5.77% |
2018 Q2 | 24.29 Million EUR | 73.83% |
2018 FY | 49.99 Million EUR | 178.36% |
2017 FY | 17.96 Million EUR | -48.61% |
2017 Q4 | 13.97 Million EUR | 250.97% |
2017 Q2 | 3.98 Million EUR | 0.0% |
2016 FY | 34.95 Million EUR | 5.32% |
2015 FY | 33.18 Million EUR | 0.6% |
2014 FY | 32.98 Million EUR | 2.94% |
2013 FY | 32.04 Million EUR | 22.32% |
2012 FY | 26.19 Million EUR | -25.03% |
2011 FY | 34.94 Million EUR | 4.45% |
2010 FY | 33.45 Million EUR | 3.01% |
2009 FY | 32.47 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Biosynex SA | 86.53 Million EUR | -33.975% |
Predilife S.A. | 4.14 Million EUR | -2694.117% |
bioMérieux S.A. | 1.44 Billion EUR | 91.991% |
Eurofins Scientific SE | 73.6 Million EUR | -57.523% |